James Gale

James Gale

Directeur/Membre du Conseil chez HYLORIS PHARMACEUTICALS SA

Fortune : 217 485 $ au 30/06/2024

74 ans
Health Technology
Commercial Services
Finance

Profil

James (Jim) Gale is the founding partner of Signet Healthcare Partners.
Jim has over 35 years of healthcare investing and finance experience.
He is currently the Chairman of the Board of Bionpharma, Inc; lead director of Knight Therapeutics Inc. (TSX: GUD); and also serves on the Board of Directors of the following Signet portfolio companies: Juno Pharmaceuticals Corp, Chr.
Olesen Synthesis A/S, Pharmaceutics International (Pii), RK Pharma, and Ascendia Pharmaceuticals.
He also serves on the Board of Hyloris Pharmaceuticals SA (Euronext: HYL) and Cerium Pharmaceuticals.
Prior portfolio company Boards include: Advantice Health (acquired by TA Associates), Arbor Pharmaceuticals, Amarin Corporation, eResearch Technologies Inc., Teligent Inc, and Valera Pharmaceuticals.
Prior to founding Signet, Jim was head of principal investment activities and head of investment banking for Gruntal & Co., LLC.
While at Gruntal, he made a number of investments including Andrx Corporation, Royce Laboratories (merged with Watson Pharmaceuticals), Lifecell Corporation (now part of AbbVie), Neurocrine Biosciences, and BML Pharmaceuticals (acquired by Endo Pharmaceuticals).
Prior to joining Gruntal, he originated and managed private equity investments for the Home Insurance Co., Gruntal’s parent.
Earlier in his career, Jim was a senior investment banker at E.F.
Hutton & Co. Jim received his Masters of Business Administration from the University of Chicago.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
17/05/2024 52 406 ( 0,05% ) 217 485 $ 30/06/2024

Postes actifs de James Gale

SociétésPosteDébut
HYLORIS PHARMACEUTICALS SA Directeur/Membre du Conseil 01/01/2020
KNIGHT THERAPEUTICS INC. Directeur/Membre du Conseil 01/09/2021
LEE'S PHARMACEUTICAL HOLDINGS LIMITED Directeur/Membre du Conseil 02/01/2022
Président -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
░░░░ ░░░░░░░░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
Tous les postes actifs de James Gale

Anciens postes connus de James Gale

SociétésPosteFin
░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░ -
░░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de James Gale

Formation de James Gale

University of Arizona Undergraduate Degree
The University of Chicago Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de James Gale

Relations

100 +

Relations au 1er degré

45

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées5
AVANTIUM N.V.

Producer Manufacturing

HYLORIS PHARMACEUTICALS SA

Health Technology

KNIGHT THERAPEUTICS INC.

Health Technology

AMARIN CORPORATION PLC

Health Technology

LEE'S PHARMACEUTICAL HOLDINGS LIMITED

Health Technology

Entreprise privées38

Health Technology

Health Technology

Electronic Technology

Health Technology

Health Technology

Commercial Services

Finance

Gruntal & Co. LLC

Government

Health Technology

Finance

E.F. Hutton & Co. (London) Ltd.

Finance

Finance

Producer Manufacturing

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Commercial Services

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Technology

Distribution Services

Commercial Services

Health Technology

Commercial Services

Home Insurance Co.

Finance

Health Technology

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. James Gale